Effect of Semaglutide on Subclinical Atherosclerosis and Cardiometabolic Compensation: A Real-World Study in Patients with Type 2 Diabetes.

Angelo Maria PattiRosaria Vincenza GiglioAlberto AllottaAndreina BrunoTommaso Di BellaAnca Mihaela Pantea Stoian Marcello Ciaccio Manfredi Rizzo

Published in: Biomedicines (2023)

Our findings suggest the effect of injectable semaglutide on atherosclerosis as a key CV protective mechanism. Considering the favorable effects on atherogenic lipoproteins and hepatic steatosis indices, our results support the pleiotropic effect of semaglutide beyond glycemic control.

Keyphrases

glycemic control
type diabetes
cardiovascular disease
blood glucose
weight loss
metabolic syndrome
adipose tissue
hyaluronic acid